Time to take your Bi-polar meds. When the "merger" first hit the news, you were so excited and hyping the move. You argued with anyone that stated the obvious re: Synageva's lack of a pipeline and being a cash funnel.
Now you're slamming the stock after a run of over 100%.
I'd really like to know who is paying you to post because you seem to lack any reason. Please tell me this isn't how your mind works.
I welcome the recent share price increase but it is perfectly reasonable to ask what Sanj and the board are doing to increase shareholder value. All I see are announcements about presentations at conferences, no details on what was presented and how they are divvying up the Trimeris cash.